Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BGLC
#8992
BioNexus Gene Lab Corp Common stock
2.265
0
USD
-2.37%
Setor:
Materiais-primas
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-2.37%
Mudança mensal
+0.89%
Mudança em 6 meses
+0.89%
Mudança anual
+0.89%
Fechamento anterior
2.320
0
Open
2.236
0
Bid
2.265
0
Ask
2.268
0
Low
2.230
0
High
2.299
9
Volume
7
Mercados
Ações
Materiais-primas
BGLC
Open full chart
Financials
Overview
Relatórios
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.43 M
1.43 M
1.45 M
1.77 M
17.97 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.08
-0.04
-0.23
-0.15
-0.26
Return on equity %
0.16
0.1
-0.05
-0.27
-0.19
-0.31
Return on invested capital %
229.76
110.58
-16.47
-150.85
-85.49
—
Gross margin %
15.1
16.42
11.52
13.61
13.56
59.45
Operating margin %
11.18
7.9
-2.66
-26.54
-16.55
-100.09
EBITDA margin %
10.38
8.06
-3.51
-30.73
68.16
218.28
Net margin %
9.61
5.62
-3.26
-26.91
-16.81
-98.1
Liquidity ratios
Quick ratio
2.02
2.42
2.52
4.24
3.1
16.28
Current ratio
2.37
3.07
3
4.93
3.81
19.93
Inventory turnover
—
—
—
0
0.08
0.08
Asset turnover
2.01
1.36
1.19
0.97
0.91
0.99
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
-0.13
-1.14
EBIT per share
—
—
—
—
0.35
-0.41
EBITDA per share
—
—
—
—
0.36
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
0.09
—
Net current asset value per share
—
—
—
—
0.42
7.46
Tangible book value per share
—
—
—
—
0.47
8.88
Working capital per share
—
—
—
—
0.31
5.91
Book value per share
—
—
—
—
0.47
8.88
Notícias
BioNexus Gene Lab nomeia diretor comercial na Fidelion
BioNexus Gene Lab appoints commercial officer at Fidelion
BioNexus Gene Lab conclui acordo estratégico com Fidelion Diagnostics
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics
Ações da BioNexus Gene Lab caem após garantir linha de crédito de US$ 500 milhões
BioNexus Gene Lab stock falls after securing $500M equity facility
BioNexus Gene Lab secures $500 million equity purchase agreement
Ações da BioNexus Gene Lab sobem após garantir facilidade de capital de US$ 500 milhões
BioNexus Gene Lab stock climbs after securing $500 million equity facility
BioNexus Gene Lab forma parceria para comercializar plataforma de biópsia líquida
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform
Ações da BioNexus Gene Lab disparam após acordos estratégicos de testes MRD